Volume 12 Supplement 1

11th Annual Conference of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)

Open Access

The importance of early COPD diagnosis during a smoking cessation program

  • Eleni Ischaki1Email author,
  • Eleni Litsiou1,
  • Vasiliki Saltagianni1,
  • Ioanna Nikoloutsou1,
  • Aikaterini Tsoutsa1,
  • Andreas Asimakos1,
  • Spyros Zakynthinos1 and
  • Paraskevi Katsaounou1
Tobacco Induced Diseases201412(Suppl 1):A22

https://doi.org/10.1186/1617-9625-12-S1-A22

Published: 6 June 2014

Background

Many patients with mild–moderate COPD (chronic obstructive pulmonary disease), are asymptomatic. Since expressed symptoms are usually mild and mostly attributed to age, they are often underestimated [1, 2]. Thus early COPD patients usually remain undiagnosed [3]. The aim of the study is to evaluate the rates of undiagnosed COPD cases in early stages of the disease (stage I and II according to GOLD classification), [4] in our smoking cessation program and to assess the effectiveness of COPD diagnosis as a motivational tool for quitting smoking.

Materials and methods

551 current smokers, aged ≥18 years old, attended voluntarily the smoking cessation program in our outpatient smoking cessation clinic. All smokers performed spirometry. Behavioral counseling and pharmacotherapy with varenicline were administered to all participants.

Results

During the study, 85 of 551 smokers were diagnosed for COPD. Only 5 of them were previously diagnosed with the disease (2 in stage II, 2 in stage III and 1 in stage IV). None of them reported symptoms. Smoking abstinence rates at 3 months was recorded. Overall smoking cessation rates three months after behavioral counseling was 55% (n=303). This percentage was higher in first diagnosed COPD patients, as shown in Table 1.
Table 1

COPD smokers that attended our Smoking Cessation Clinic

COPD stages

Ι

ΙΙ

ΙΙΙ

IV

n

39

35

11

1

First diagnosis

39

33

9

0

Abstinence rates after 3 months *

30 (76.9%)

30 (85.79%)

7 (63.6%)

1 (100%)

* Abstinence rates are referred to the summation of old and new COPD cases

Conclusions

A smoking cessation program is a great opportunity to identify undiagnosed COPD cases. COPD diagnosis is an effective motive to quit smoking. Smoking cessation combined with treatment based on COPD severity can modify the progression of the disease. Namely the rate of yearly FEV1 decline and COPD exacerbations are reduced after smoking cessation and patients’ health related quality of life is improved. The above effects are maximized when smoking cessation is achieved in early COPD stages [5, 6]

Authors’ Affiliations

(1)
Pulmonary and Critical Care Department, Evangelismos Hospital

References

  1. Akamatsu K, Yamagata T, Kida Y, Tanaka H, Ueda H, Ichinose M: Poor sensitivity of symptoms in early detection of COPD. COPD. 2008, 5 (5): 269-73. 10.1080/15412550802363303.View ArticlePubMedGoogle Scholar
  2. Buffels J, Degryse J, Heyrman J, Decramer M, DIDASCO Study: Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004, 125 (4): 1394-9. 10.1378/chest.125.4.1394.View ArticlePubMedGoogle Scholar
  3. Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J: Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009, 64 (10): 863-8. 10.1136/thx.2009.115725.View ArticlePubMedGoogle Scholar
  4. Global Strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease. Global initiative for chronic Obstructive Lung Disease (GOLD). 2012Google Scholar
  5. Decramer M, Cooper CB: Treatment of COPD: the sooner the better?. Thorax. 2010, 65 (9): 837-41. 10.1136/thx.2009.133355.View ArticlePubMedGoogle Scholar
  6. Price D, Freeman D, Cleland J, Kaplan A, Cerasoli F: Earlier diagnosis and earlier treatment of COPD in primary care. Primary Care Respiratory Journal. 2011, 20 (1): 15-22. 10.4104/pcrj.2010.00060.View ArticlePubMedGoogle Scholar

Copyright

© Ischaki et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement